Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 11/20 | 0.39 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.39 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.38 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.38 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.38 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | P2RY14 | Q15391 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18671502 | 0.79 | SLC28A1 (0.37) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL25717866 | 0.78 | SLC28A1 (0.43) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL18512756 | 0.77 | POLB (0.41) | P2RY2SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL25718210 | 0.76 | — | — | |
| SCHEMBL17357612 | 0.76 | P2RY6 (0.39) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL26471944 | 0.76 | P2RY6 (0.39) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL26012227 | 0.76 | P2RY6 (0.39) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL16640099 | 0.76 | P2RY6 (0.39) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL20725042 | 0.75 | P2RY2 (0.46) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL18512852 | 0.75 | P2RY2 (0.46) | P2RY2P2RY4P2RY6P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131914-B1 | 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX PHARMACEUTICALS LLC (US) | 2023-05-10 | — | — | EP | disclosed |